Skip to content
Search

Latest Stories

RSG publishes proposals for better pharmacy representation

The Review Steering Group (RSG) has published its proposals to reform representation and support provided by PSNC and LPCs to community pharmacies in England.

Contractors will have four weeks to read and digest the recommendations before a three-week voting period commences on Friday, May 27.


The RSG said the proposals with 37 recommendations are a result of 15 months of "extensive listening, exploratory work, analysis, and discussion" across the sector which have come about nearly two years after Professor David Wright and his team at the University of East Anglia published a report on contractor representation and support in England.

The proposals make recommendations to strengthen governance, better align the sector with the wider NHS, appropriately resource representatives and promote collaboration.

While 23 proposals are regarding PSNC alone, there are six recommendations for the LPCs to consider with 10 will require both parties to consider jointly.

PSNC CEO Janet Morrison said she "absolutely" supports these proposals which could "help us and the LPCs to get better outcomes" to all pharmacies, adding: "I believe these RSG proposals will help us to work better together".

"Strengthening governance, improving collaboration, aligning with the NHS and ensuring contractors’ money is spent most effectively to get them the best value, must be principles that are difficult for anyone (in any sector) to argue against.

"I hope community pharmacy contractors will agree. A no vote on these proposals, in my view, simply makes us, as a sector, less credible in the eyes of the NHS and Government, who are ultimately the people we need to be focused on."

The proposals include a renewed focus on bringing local and wider expertise to central decision-making so PSNC can work with "one vision and strategy" for the entire sector.

PSNC vice-chair, Bharat Patel, said: "I’ll certainly be voting for these proposals, and I would encourage others to do likewise: if we do, we are setting a pathway to change which as both an independent contractor and PSNC vice-chair I am excited about and committed to.

"If we don’t, and choose instead to keep debating what might have been done differently, then we cannot complain when our representatives – local and national – find themselves unable to move forward, and unable to get better answers on our behalf.”

Commenting on the RSG proposals, the National Pharmacy Association (NPA) said it would "consult with our members over the coming weeks before declaring our final position".

It added: "The NPA will support members in understanding the implications of these proposals. We encourage our members to attend the PSNC sessions, and will ourselves organise a ‘Townhall’ meeting in May to facilitate debate within the independent sector."

Malcolm Harrison, chief executive of the Company Chemists’ Association, welcomed the publication of the proposals and hoped that for "a better resourced PSNC" so its negotiating capacity is improved.

He said: "We are confident that these proposals will provide stronger governance, better representation both nationally and locally and greater value for money for contractors."

The proposals are available on the RSG website here.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less